# HEALTH_RESEARCHER -- Conversation & Evaluation

**Timestamp:** 20260305_210549
**Run:** single
**Prompt Version:** feat/setup-evals@f658e91a9
**Judge Model:** gpt-4.1-mini
**Mode:** HTTP E2E
**Persona:** Dr. Thandi is a 38-year-old public health researcher specializing in infectious diseases in Southern...
**Turns:** 8

## Evaluation Results

| Metric | Score | Threshold | Status |
|---|---|---|---|
| Conversation Completeness [Conversational GEval] | 1.00 | 0.5 | PASS |
| Data Accuracy | 1.00 | 0.8 | PASS |
| Claim Tagging & PCN | 1.00 | 0.8 | PASS |
| Context Retention | 0.90 | 0.6 | PASS |
| Data Gap Handling | 1.00 | 0.5 | PASS |
| Comparability Warnings | 1.00 | 0.4 | PASS |
| Content Structure | 0.93 | 0.4 | PASS |
| Follow-up Suggestions | 0.94 | 0.4 | PASS |
| Latest Data Note | 1.00 | 0.4 | PASS |
| Source Citation | 1.00 | 0.6 | PASS |
| Data Formatting | 1.00 | 0.4 | PASS |
| Inline Explanations | 0.94 | 0.4 | PASS |
| Progressive Disclosure | 0.98 | 0.4 | PASS |

**Pass Rate:** 13/13 (100%)

## Insights

### Strengths

- **Perfect/near-perfect scores (>=0.95):** **Claim Tagging & PCN**, **Comparability Warnings**, **Conversation Completeness [Conversational GEval]**, **Data Accuracy**, **Data Formatting**, **Data Gap Handling**, **Latest Data Note**, **Progressive Disclosure**, **Source Citation**
- **Content Structure** (0.93): Strong performance
- **Context Retention** (0.90): Strong performance
- **Follow-up Suggestions** (0.94): Strong performance
- **Inline Explanations** (0.94): Strong performance

### No Failures!

All metrics passed their thresholds.

---

## Judge Reasoning

<details>
<summary>📊 Conversation Completeness [Conversational GEval] (1.00 ✅)</summary>

**Reason:** All user intentions were fully met with detailed, accurate data and explanations. The assistant provided comprehensive HIV prevalence and maternal mortality data for South Africa, Botswana, and Namibia, including trends over ten years, fulfilling the initial request. Upon the user's request for comparative line charts, the assistant supplied clear chart descriptions with data sources and structure. When asked about data collection methods and modeling approaches, the assistant delivered an in-depth, precise explanation covering both HIV and maternal mortality indicators, including limitations and uncertainties, addressing the user's intention to understand data provenance and caveats. Finally, the assistant drafted a concise, well-structured methods and limitations section suitable for a paper, directly responding to the last user query. Throughout, no data was fabricated, gaps were not present, and explanations were thorough, aligning perfectly with the evaluation rubric and steps.

**Verbose Logs:**

```
Criteria:
Evaluate whether the chatbot addresses all user intentions across the conversation. For EACH user intention, determine if the chatbot: (A) Fulfilled it directly with data — classify as MET. (B) Could not fulfill it because the data is genuinely unavailable in the Data360/World Bank API, BUT the chatbot: (i) explicitly stated the data gap, (ii) explained WHY it's missing, (iii) suggested alternative data sources or approaches. This is CORRECT BEHAVIOR per the product spec and should be classified as PARTIALLY MET (not failed). (C) Ignored the intention, gave a vague non-answer, or fabricated data — classify as UNMET. IMPORTANT: The chatbot is constrained to a specific data API (Data360 / World Bank). When that API genuinely lacks data for a country, time period, or indicator, the chatbot MUST NOT fabricate values. Instead, graceful handling (explain gap + suggest alternatives) is the expected behavior and should NOT be penalized as a failure.
 
 
Evaluation Steps:
[
    "Identify all user intentions across the conversation",
    "For each intention, classify as: MET (data provided), PARTIALLY MET (data unavailable but gap explained + alternatives suggested), or UNMET (ignored/vague/fabricated)
",
    "Score = (MET count + 0.5 * PARTIALLY_MET count) / total intentions",
    "If all unmeetable intentions were handled with explicit gap explanation + alternatives, the minimum score should be 0.5
"
] 
 
Rubric:
0-2: Most intentions unmet, no gap handling, or data fabricated.
3-4: Multiple unmet intentions without proper gap explanation or alternatives.
5-6: Some intentions met, some gaps handled gracefully, minor issues.
7-8: Most intentions met; any gaps handled gracefully with explanation + alternatives.
9-10: All user intentions fully met with data.
```

</details>

<details>
<summary>📊 Data Accuracy (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Claim Tagging & PCN (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Context Retention (0.90 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=0.90). Turn 2: The response correctly retains context by using the same indicator IDs (WB_WDI_SH_DYN_AIDS_ZS and WB_WDI_SH_STA_MMRT) and country codes as in prior turns, maintaining data provenance. It does not re-search resolved indicators and maintains consistency with prior data availability, providing clear labels and data source notes. Minor deduction is due to the brief analysis rather than deeper integration of prior numeric claims. | Turn 3: The response correctly retains context by referencing the same indicator IDs (WB_WDI_SH_DYN_AIDS_ZS and WB_WDI_SH_STA_MMRT) used in prior turns, maintaining data provenance. It does not re-search resolved indicators and consistently presents the modeled nature and uncertainties of the HIV prevalence and maternal mortality estimates, aligning with prior assertions about data limitations. Minor deduction is due to the lack of explicit mention of claim_ids in numeric references, but overall consistency and context retention are strong. | Turn 4: The response correctly retains context by providing detailed methods and limitations consistent with prior turns, referencing the same indicators without inventing new claim_ids or contradicting earlier data availability assertions. It avoids re-searching resolved indicators and maintains consistency about modeled estimates and their uncertainties, though it does not explicitly cite claim_ids, which slightly limits perfect provenance tracking.

</details>

<details>
<summary>📊 Data Gap Handling (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Comparability Warnings (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Content Structure (0.93 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=0.93). Turn 1: The response includes clear section labels for Data, Analysis, and Note, effectively separating facts from interpretation. It provides detailed data tables and trend analysis for both HIV prevalence and maternal mortality. Methodological caveats are noted under the Note section, addressing limitations. However, the Limitations label is not explicitly used, and some methodological caveats are embedded in the Note rather than a distinct Limitations section, preventing a perfect score.

</details>

<details>
<summary>📊 Follow-up Suggestions (0.94 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=0.94). Turn 1: The response includes a 'Suggested follow-ups:' section with three clearly user-phrased questions, appropriately labeled and relevant to the data provided. The questions are phrased naturally from a user's perspective, fulfilling the rubric's highest criteria. However, minor improvements could be made to ensure all questions are explicitly phrased as direct user inquiries.

</details>

<details>
<summary>📊 Latest Data Note (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). Turn 1: The response explicitly includes the latest available data years (2024 for HIV prevalence and 2023 for maternal mortality), fulfilling the rubric's highest standard. It also provides a clear note indicating the use of latest data and detailed year-by-year comparisons, directly addressing the user's request for the latest data and trend analysis over the past decade.

</details>

<details>
<summary>📊 Source Citation (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Data Formatting (1.00 ✅)</summary>

**Reason:** Aggregated from 4 turns (min=1.00). All turns passed.

</details>

<details>
<summary>📊 Inline Explanations (0.94 ✅)</summary>

**Reason:** Aggregated from 4 turns (mean=0.94). Turn 1: The response identifies key technical terms such as 'HIV prevalence,' 'maternal mortality ratio,' 'UNAIDS modeled estimates,' and 'MMEIG modeled estimates,' and provides clear, concise inline explanations on first use. Most terms are well contextualized, including acronyms like MMR and references to data sources. Minor room for improvement exists in explicitly defining some acronyms (e.g., ART) inline, but overall the explanations are thorough and integrated. | Turn 2: The response identifies key technical terms such as 'HIV prevalence,' 'maternal mortality ratio,' and indicator codes (e.g., WB_WDI_SH_DYN_AIDS_ZS) and provides clear, concise inline explanations on first use, including age ranges and units. Data source notes are included for transparency. The explanations are well integrated and mostly comprehensive, though a minor improvement could be made by explicitly defining acronyms like ART or UNAIDS within the text. Overall, the response meets the rubric criteria for explaining most terms inline. | Turn 3: The response identifies all key technical terms and acronyms such as HIV prevalence, UNAIDS Spectrum model, MMEIG, ART, PMTCT, CRVS, and sisterhood methods, providing clear, concise, and inline plain-language explanations on first use. It thoroughly explains data sources, modeling steps, and known limitations for both HIV prevalence and maternal mortality estimates, meeting the highest rubric standard. | Turn 4: The response identifies all key technical terms and acronyms such as HIV prevalence, maternal mortality ratio, UNAIDS, Spectrum model, and MMEIG, providing clear, concise, and inline explanations on first use. The methods and limitations sections thoroughly explain the data sources, modeling approaches, and known uncertainties, adhering closely to the evaluation steps and rubric by ensuring all terms are well-defined and contextualized.

</details>

<details>
<summary>📊 Progressive Disclosure (0.98 ✅)</summary>

**Reason:** Aggregated from 4 turns (mean=0.98). Turn 1: The response begins with a clear summary providing key insights on HIV prevalence and maternal mortality trends, fulfilling the first evaluation step. It presents structured data with progressive detail, including latest figures, ten-year comparisons, and intermediate points, avoiding excessive upfront data dumping. The inclusion of an analysis section synthesizes the data effectively. Additionally, the response offers multiple relevant follow-up questions for drill-down, meeting the third evaluation criterion. Minor markdown formatting and data density slightly reduce perfect flow, but overall it demonstrates strong structure and insight leadership.

</details>

---

## Conversation

### User (Turn 1)

Hello, could you provide the latest HIV prevalence and maternal mortality data for South Africa, Botswana, and Namibia? I'm looking to start a comparative analysis of trends over the past ten years.

### Assistant

<details>
<summary>🔍 Agent Actions (14 events, 6 tool calls)</summary>

**🧭 Routing**

Understanding your question…User requests recent HIV prevalence and maternal mortality data plus 10-year trends for specific countries, which are development indicators available via Data360/World Bank tools.

<hr>

**🔧 Tool Call #1: `data360_search_indicators`**
```
  query: HIV prevalence (% of population ages 15-49)
  required_country: South Africa, Botswana, Namibia
  limit: 10
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "count": 10,
  "total_count": 8778,
  "offset": 0,
  "has_more": true,
  "next_offset": 10,
  "indicators": [
    {
      "idno": "WB_WDI_SH_DYN_AIDS_ZS",
      "database_id": "WB_WDI",
      "name": "Prevalence of HIV, total (% of population ages 15-49)",
      "truncated_definition": "Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.",
      "periodicity": "Annual",
      "latest_data": "2024",
      "time_period_range": "1990-2024",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_WDI_SH_HIV_1524_FE_ZS",
      "database_id": "WB_WDI",
      "name": "Prevalence of HIV, female (% ages 15-24)",
      "truncated_definition": "Prevalence of HIV, female is the percentage of females who are infected with HIV. Youth rates are as",
      "periodicity": "Annual",
      "latest_data": "2024",
      "time_period_range": "1990-2024",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_WDI_SH_HIV_INCD_ZS",
      "database_id": "WB_WDI",
      "name": "Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)",
      "truncated_definition": "Number of new HIV infections among uninfected populations ages 15-49 expressed per 1,000 uninfected ",
      "periodicity": "Annual",
      "latest_data": "2024",
      "time_period_range": "1990-2024",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_HNP_SH_DYN_AIDS_ZS",
      "database_id": "WB_HNP",
      "name": "Prevalence of HIV (% of population with relevant ages)",
      "truncated_definition": "Prevalence of HIV refers to the percentage of people ages who are infected with HIV.  The data is av",
      "periodicity": "Annual",
      "latest_data": "2023",
      "time_period_range": "1960-2023",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_HNP_SP_DYN_CONM_AL_ZS",
      "database_id": "WB_HNP",
      "name": "Contraceptive preva
... (truncated)
```

</details>

<hr>

**🔧 Tool Call #2: `data360_search_indicators`**
```
  query: maternal mortality ratio (modeled estimate, per 100,000 live births)
  required_country: South Africa, Botswana, Namibia
  limit: 10
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "count": 10,
  "total_count": 1753,
  "offset": 0,
  "has_more": true,
  "next_offset": 10,
  "indicators": [
    {
      "idno": "WB_HNP_SH_STA_MMRT",
      "database_id": "WB_HNP",
      "name": "Maternal mortality ratio (modeled estimate, per 100,000 live births)",
      "truncated_definition": "Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant",
      "periodicity": "Annual",
      "latest_data": "2023",
      "time_period_range": "1960-2023",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_HNP_SH_STA_MMRT_NE",
      "database_id": "WB_HNP",
      "name": "Maternal mortality ratio (national estimate, per 100,000 live births)",
      "truncated_definition": "Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant",
      "periodicity": "Annual",
      "latest_data": "2023",
      "time_period_range": "1960-2023",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_GS_SH_STA_MMRT",
      "database_id": "WB_GS",
      "name": "Maternal mortality ratio (per 100,000 live births)",
      "truncated_definition": "Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant",
      "periodicity": "Annual",
      "latest_data": "2023",
      "time_period_range": "1960-2023",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_WDI_SH_STA_MMRT_NE",
      "database_id": "WB_WDI",
      "name": "Maternal mortality ratio (national estimate, per 100,000 live births)",
      "truncated_definition": "Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant",
      "periodicity": "Annual",
      "latest_data": "2023",
      "time_period_range": "1985-2023",
      "covers_country": true,
      "dimensions": null
    },
    {
      "idno": "WB_WDI_SH_STA_MMRT",
      "database_id": "WB_WDI",
     
... (truncated)
```

</details>

<hr>

**🔧 Tool Call #3: `data360_get_data`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_DYN_AIDS_ZS
  disaggregation_filters: {"REF_AREA": "ZAF,BWA,NAM"}
  start_year: 2014
  end_year: 2024
  limit: 100
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "count": 33,
  "total_count": null,
  "offset": 0,
  "has_more": false,
  "next_offset": null,
  "data": [
    {
      "OBS_VALUE": "17.2",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Prevalence of HIV, total (% of population ages 15-49)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "DATABASE_ID": "WB_WDI",
      "INDICATOR": "WB_WDI_SH_DYN_AIDS_ZS",
      "REF_AREA": "ZAF",
      "SEX": "_T",
      "AGE": "_T",
      "URBANISATION": "_T",
      "COMP_BREAKDOWN_1": "_Z",
      "COMP_BREAKDOWN_2": "_Z",
      "COMP_BREAKDOWN_3": "_Z",
      "TIME_PERIOD": "2024",
      "FREQ": "A",
      "UNIT_MEASURE": "PT_POP_SUB",
      "UNIT_TYPE": null,
      "claim_id": "3878cdc4"
    },
    {
      "OBS_VALUE": "9",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Prevalence of HIV, total (% of population ages 15-49)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "DATABASE_ID": "WB_WDI",
      "INDICATOR": "WB_WDI_SH_DYN_AIDS_ZS",
      "REF_AREA": "NAM",
      "SEX": "_T",
      "AGE": "_T",
      "URBANISATION": "_T",
      "COMP_BREAKDOWN_1": "_Z",
      "COMP_BREAKDOWN_2": "_Z",
      "COMP_BREAKDOWN_3": "_Z",
      "TIME_PERIOD": "2024",
      "FREQ": "A",
      "UNIT_MEASURE": "PT_POP_SUB",
      "UNIT_TYPE": null,
      "claim_id": "e6455594"
    },
    {
      "OBS_VALUE": "15.7",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Prevalence of HIV, total (% of population ages 15-49)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "DATABASE_ID": "WB_WDI",
      "INDICATOR":
... (truncated)
```

</details>

<hr>

**🔧 Tool Call #4: `data360_get_metadata`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_DYN_AIDS_ZS
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "indicator_metadata": {
    "idno": "WB_WDI_SH_DYN_AIDS_ZS",
    "doi": null,
    "name": "Prevalence of HIV, total (% of population ages 15-49)",
    "display_name": null,
    "database_id": "WB_WDI",
    "database_name": "World Development Indicators (WDI)",
    "date_last_update": null,
    "date_released": null,
    "measurement_unit": "Percentage",
    "release_calendar": null,
    "periodicity": "Annual",
    "base_period": null,
    "definition_short": null,
    "definition_long": "Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.",
    "statistical_concept": "HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable.",
    "methodology": "UNAIDS produces annual HIV/AIDS-related indicators using a common modelling framework (Spectrum). The model integrates country-reported data on HIV surveillance, antiretroviral therapy (ART) coverage, demographic information, and established patterns of HIV transmission, disease progression, and survival. Because many countries lack complete case reporting or cause-of-death data, these figures are modelled estimates and include uncertainty ranges. UNAIDS updates the estimates each year as new data and methods become available, ensuring internal consistency across all HIV/AIDS-related indicators. Reference: Annex 1 Methods for deriving UNAIDS HIV estimates \u2014 2025 Global AIDS Update \u2014 AIDS, Crisis and the Power to Transform: https://www.unaids.org/sites/default/files/2025-08/JC3153_GAU25_report_annex1_en.pdf",
    "derivation": null,
    "imputation": null,
    "missing": null,
    "quality_checks": null,
    "quality_note"
... (truncated)
```

</details>

<hr>

**🔧 Tool Call #5: `data360_get_data`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_STA_MMRT
  disaggregation_filters: {"REF_AREA": "ZAF,BWA,NAM"}
  start_year: 2014
  end_year: 2024
  limit: 100
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "count": 30,
  "total_count": null,
  "offset": 0,
  "has_more": false,
  "next_offset": null,
  "data": [
    {
      "OBS_VALUE": "118",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Maternal mortality ratio (modeled estimate, per 100,000 live births)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "DATABASE_ID": "WB_WDI",
      "INDICATOR": "WB_WDI_SH_STA_MMRT",
      "REF_AREA": "ZAF",
      "SEX": "_T",
      "AGE": "_T",
      "URBANISATION": "_T",
      "COMP_BREAKDOWN_1": "_Z",
      "COMP_BREAKDOWN_2": "_Z",
      "COMP_BREAKDOWN_3": "_Z",
      "TIME_PERIOD": "2023",
      "FREQ": "A",
      "UNIT_MEASURE": "DT_10P5BR_L",
      "UNIT_TYPE": null,
      "claim_id": "b48a6b8f"
    },
    {
      "OBS_VALUE": "139",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Maternal mortality ratio (modeled estimate, per 100,000 live births)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "DATABASE_ID": "WB_WDI",
      "INDICATOR": "WB_WDI_SH_STA_MMRT",
      "REF_AREA": "NAM",
      "SEX": "_T",
      "AGE": "_T",
      "URBANISATION": "_T",
      "COMP_BREAKDOWN_1": "_Z",
      "COMP_BREAKDOWN_2": "_Z",
      "COMP_BREAKDOWN_3": "_Z",
      "TIME_PERIOD": "2023",
      "FREQ": "A",
      "UNIT_MEASURE": "DT_10P5BR_L",
      "UNIT_TYPE": null,
      "claim_id": "615382c8"
    },
    {
      "OBS_VALUE": "155",
      "TIME_FORMAT": "P1Y",
      "UNIT_MULT": 0,
      "COMMENT_OBS": null,
      "OBS_STATUS": "A",
      "OBS_CONF": "PU",
      "AGG_METHOD": "_Z",
      "DECIMALS": "2",
      "COMMENT_TS": "Maternal mortality ratio (modeled estimate, per 100,000 live births)",
      "DATA_SOURCE": "WB_WDI",
      "LATEST_DATA": true,
      "D
... (truncated)
```

</details>

<hr>

**🔧 Tool Call #6: `data360_get_metadata`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_STA_MMRT
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "indicator_metadata": {
    "idno": "WB_WDI_SH_STA_MMRT",
    "doi": null,
    "name": "Maternal mortality ratio (modeled estimate, per 100,000 live births)",
    "display_name": null,
    "database_id": "WB_WDI",
    "database_name": "World Development Indicators (WDI)",
    "date_last_update": null,
    "date_released": null,
    "measurement_unit": "Per 100,000 live births",
    "release_calendar": null,
    "periodicity": "Annual",
    "base_period": null,
    "definition_short": null,
    "definition_long": "Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).",
    "statistical_concept": "Reproductive health is a state of physical and mental well-being in relation to the reproductive system and its functions and processes. Means of achieving reproductive health include education and services during pregnancy and childbirth, safe and effective contraception, and prevention and treatment of sexually transmitted diseases. Complications of pregnancy and childbirth are the leading cause of death and disability among women of reproductive age in developing countries.\r\n\r\nMaternal mortality is generally of unknown reliability, as are many other cause-specific mortality indicators. Household surveys such as Demographic and Health Surveys attempt to measure maternal mortality by asking respondents about survivorship of sisters. The main disadvantage of this method is that the estimates of maternal mortality that it produces pertain to any time within the past few years before the survey, making them unsuitable for monitoring recent changes or observing the impact of interventions. In addition, measurement of maternal mort
... (truncated)
```

</details>

<hr>

**🧠 Thinking** (stage: interpreting)

**Intent:** Provide latest HIV prevalence and maternal mortality data and a 10‑year trend snapshot for South Africa, Botswana, and Namibia, using harmonized World Bank/UN indicators.

</details>

<details open>
<summary>✍️ Writer</summary>



**Summary (using latest available data):**  
All three countries have very high HIV prevalence among adults 15–49, with Botswana and South Africa above Namibia. Maternal mortality has fallen substantially over the past decade in South Africa and Botswana, and from very high levels in Namibia, but remains well above global averages in all three.

---

## Data

### 1. HIV prevalence, adults 15–49 (%), 2014–2024  
Indicator: **Prevalence of HIV, total (% of population ages 15–49)** — WB_WDI_SH_DYN_AIDS_ZS

**Latest year (2024):**

- South Africa: <claim id="3878cdc4" policy="auto">17.2</claim>% (2024)  
- Botswana: <claim id="afe70664" policy="auto">15.7</claim>% (2024)  
- Namibia: <claim id="e6455594" policy="auto">9.0</claim>% (2024)  

**Ten‑year comparison (2014 vs 2024):**

| Country       | 2014 HIV prevalence (% 15–49) | 2024 HIV prevalence (% 15–49) | Direction 2014–2024* |
|--------------|--------------------------------|-------------------------------|----------------------|
| South Africa | <claim id="088c80ef" policy="auto">18.3</claim>%                | <claim id="3878cdc4" policy="auto">17.2</claim>%                 | Slight decline       |
| Botswana     | <claim id="ded61aad" policy="auto">22.1</claim>%                | <claim id="afe70664" policy="auto">15.7</claim>%                 | Clear decline        |
| Namibia      | <claim id="3dc2ac45" policy="auto">12.6</claim>%                | <claim id="e6455594" policy="auto">9.0</claim>%                  | Clear decline        |

\*Intermediate points for context:

- South Africa:  
  - 2016: <claim id="3bd56225" policy="auto">18.6</claim>%  
  - 2018: <claim id="69a97918" policy="auto">18.6</claim>%  
  - 2020: <claim id="4f47cc43" policy="auto">18.4</claim>%  
  - 2022: <claim id="09b4cdd6" policy="auto">17.9</claim>%  
  - 2023: <claim id="98d86436" policy="auto">17.6</claim>%  

- Botswana:  
  - 2014: <claim id="ded61aad" policy="auto">22.1</claim>%  
  - 2016: <claim id="d89340fe" policy="auto">21.4</claim>%  
  - 2018: <claim id="c99b16b6" policy="auto">20.3</claim>%  
  - 2019: <claim id="624f618f" policy="auto">19.7</claim>%  
  - 2020: <claim id="c986de9d" policy="auto">19.0</claim>%  
  - 2021: <claim id="07d599a1" policy="auto">18.2</claim>%  
  - 2022: <claim id="9a286d05" policy="auto">17.4</claim>%  
  - 2023: <claim id="147d9d7a" policy="auto">16.6</claim>%  
  - 2024: <claim id="afe70664" policy="auto">15.7</claim>%  

- Namibia:  
  - 2014: <claim id="3dc2ac45" policy="auto">12.6</claim>%  
  - 2015: <claim id="164c3672" policy="auto">12.4</claim>%  
  - 2016: <claim id="c612e3c7" policy="auto">12.1</claim>%  
  - 2017: <claim id="e0890327" policy="auto">11.8</claim>%  
  - 2018: <claim id="eb101cb2" policy="auto">11.5</claim>%  
  - 2019: <claim id="4275771c" policy="auto">11.1</claim>%  
  - 2020: <claim id="0c611505" policy="auto">10.6</claim>%  
  - 2021: <claim id="a5047eab" policy="auto">10.2</claim>%  
  - 2022: <claim id="26482c53" policy="auto">9.8</claim>%  
  - 2023: <claim id="1be9fe5f" policy="auto">9.4</claim>%  
  - 2024: <claim id="e6455594" policy="auto">9.0</claim>%  

---

### 2. Maternal mortality ratio (per 100,000 live births), 2014–2023  
Indicator: **Maternal mortality ratio (modeled estimate, per 100,000 live births)** — WB_WDI_SH_STA_MMRT

**Latest year (2023):**

- South Africa: <claim id="b48a6b8f" policy="auto">118</claim> deaths per 100,000 live births (2023)  
- Botswana: <claim id="513dd7a2" policy="auto">155</claim> per 100,000 (2023)  
- Namibia: <claim id="615382c8" policy="auto">139</claim> per 100,000 (2023)  

**Ten‑year comparison (2014 vs 2023):**

| Country       | 2014 MMR (per 100,000) | 2023 MMR (per 100,000) | Direction 2014–2023*          |
|--------------|-------------------------|-------------------------|-------------------------------|
| South Africa | <claim id="35bfa15a" policy="auto">162</claim>                 | <claim id="b48a6b8f" policy="auto">118</claim>                 | Decline (overall)            |
| Botswana     | <claim id="74ff37f2" policy="auto">212</claim>                 | <claim id="513dd7a2" policy="auto">155</claim>                 | Decline (with volatility)    |
| Namibia      | <claim id="c166f92e" policy="auto">369</claim>                 | <claim id="615382c8" policy="auto">139</claim>                 | Large decline                |

\*Intermediate points for context:

- **South Africa**  
  - 2015: <claim id="b8353256" policy="auto">150</claim>  
  - 2016: <claim id="57abc1d6" policy="auto">141</claim>  
  - 2017: <claim id="7851120f" policy="auto">134</claim>  
  - 2018: <claim id="8c3ba5b4" policy="auto">128</claim>  
  - 2019: <claim id="a8a15590" policy="auto">119</claim>  
  - 2020: <claim id="3d773beb" policy="auto">118</claim>  
  - 2021: <claim id="3a3134ac" policy="auto">191</claim> (COVID‑era spike)  
  - 2022: <claim id="82777120" policy="auto">129</claim>  
  - 2023: <claim id="b48a6b8f" policy="auto">118</claim>  

- **Botswana**  
  - 2014: <claim id="74ff37f2" policy="auto">212</claim>  
  - 2015: <claim id="cb75c1b3" policy="auto">141</claim>  
  - 2016: <claim id="5aee03e6" policy="auto">72</claim>  
  - 2017: <claim id="5e3550fb" policy="auto">46</claim>  
  - 2018: <claim id="d73d660c" policy="auto">99</claim>  
  - 2019: <claim id="e3ada008" policy="auto">100</claim>  
  - 2020: <claim id="82b263ed" policy="auto">98</claim>  
  - 2021: <claim id="2d8554c5" policy="auto">165</claim>  
  - 2022: <claim id="6ca0eef0" policy="auto">120</claim>  
  - 2023: <claim id="513dd7a2" policy="auto">155</claim>  

- **Namibia**  
  - 2014: <claim id="c166f92e" policy="auto">369</claim>  
  - 2015: <claim id="da1b25ea" policy="auto">307</claim>  
  - 2016: <claim id="3e88a750" policy="auto">250</claim>  
  - 2017: <claim id="ad3f0c01" policy="auto">213</claim>  
  - 2018: <claim id="036a441b" policy="auto">198</claim>  
  - 2019: <claim id="9f8bba70" policy="auto">175</claim>  
  - 2020: <claim id="67cf8fa4" policy="auto">143</claim>  
  - 2021: <claim id="d3255a18" policy="auto">254</claim> (COVID‑era spike)  
  - 2022: <claim id="a7abaffd" policy="auto">127</claim>  
  - 2023: <claim id="615382c8" policy="auto">139</claim>  

---

## Analysis

**HIV prevalence (2014–2024):**

- All three countries have **very high generalized HIV epidemics** by global standards.  
- Botswana has reduced prevalence from about <claim id="ded61aad" policy="auto">22.1</claim>% (2014) to <claim id="afe70664" policy="auto">15.7</claim>% (2024), a sizeable decline consistent with strong treatment and prevention coverage.  
- Namibia shows a steady, almost monotonic decline from <claim id="3dc2ac45" policy="auto">12.6</claim>% (2014) to <claim id="e6455594" policy="auto">9.0</claim>% (2024).  
- South Africa’s prevalence is high and relatively flat, moving from <claim id="088c80ef" policy="auto">18.3</claim>% (2014) to <claim id="3878cdc4" policy="auto">17.2</claim>% (2024). Given South Africa’s large population, even small percentage changes imply large numbers of people.

**Maternal mortality (2014–2023):**

- **South Africa**: Gradual improvement from <claim id="35bfa15a" policy="auto">162</claim> to <claim id="b48a6b8f" policy="auto">118</claim> per 100,000, with a clear spike in 2021 (<claim id="3a3134ac" policy="auto">191</claim>) likely reflecting COVID‑19 and health‑system strain.  
- **Botswana**: Very volatile but trending downward overall. Extremely low estimates in 2016–17 (<claim id="5aee03e6" policy="auto">72</claim>, <claim id="5e3550fb" policy="auto">46</claim>) suggest model uncertainty; more recent years rise again to <claim id="513dd7a2" policy="auto">155</claim> (2023).  
- **Namibia**: The largest relative improvement, from a very high <claim id="c166f92e" policy="auto">369</claim> (2014) to <claim id="615382c8" policy="auto">139</claim> (2023). Nonetheless, current levels remain high compared with global SDG target 3.1 (70 per 100,000).

**Cross‑indicator perspective:**

- High HIV prevalence has historically been a major contributor to maternal mortality in the region. The declines in HIV prevalence (especially in Botswana and Namibia) and expanded ART coverage likely contribute to improved maternal outcomes, but the relationship is mediated by broader health‑system factors (skilled birth attendance, emergency obstetric care, etc.).  
- COVID‑19‑era spikes in MMR (2021) in South Africa and Namibia highlight health‑system vulnerability even as HIV outcomes improve.

---

## Note

- **Methodological caveats:**  
  - HIV prevalence values are **UNAIDS modeled estimates**; they come with uncertainty ranges not shown here.  
  - Maternal mortality ratios are **MMEIG modeled estimates**; the metadata explicitly warns that they **should not be over‑interpreted year‑to‑year** and that historical comparability across major methodological revisions is limited. Use them primarily for broad trends rather than precise annual changes.

---

## Sources

- **World Bank — World Development Indicators (WDI)**  
  - *Prevalence of HIV, total (% of population ages 15–49)* (WB_WDI_SH_DYN_AIDS_ZS) — UNAIDS modeled estimates.  
  - *Maternal mortality ratio (modeled estimate, per 100,000 live births)* (WB_WDI_SH_STA_MMRT) — MMEIG (WHO, UNICEF, UNFPA, World Bank, UNDESA) modeled estimates.

**Suggested follow-ups:**

1. Could you generate comparative line charts for HIV prevalence and maternal mortality for South Africa, Botswana, and Namibia over the past 10–20 years?  
2. Can you break down these trends relative to regional averages (Sub‑Saharan Africa, Eastern & Southern Africa)?  
3. Can you help me identify and summarize key policy or program changes in each country that might explain shifts in HIV and maternal mortality trends?

</details>

<details>
<summary>📝 Per-Turn Scores</summary>

- **Per-Turn Comparability Warnings**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Context Retention**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Gap Handling**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Accuracy**: 1.00 ✅
  - All values for HIV prevalence and maternal mortality match the correct countries and years exactly as per the tool output. Entity names are consistent and no fabricated or guessed numbers are present. The response provides detailed, accurate data with appropriate year matching and clear referencing to source indicators.
- **Per-Turn Claim Consistency**: 1.00 ✅
  - All numeric values are correctly wrapped in <claim> tags with consistent and valid claim_ids and policy attributes. The claim_ids match exactly across repeated values within this turn, demonstrating proper reuse. There is no evidence of fabricated data or untagged values, fulfilling all rubric criteria for a perfect score.
- **Per-Turn Content Structure**: 0.93 ✅
  - The response includes clear section labels for Data, Analysis, and Note, effectively separating facts from interpretation. It provides detailed data tables and trend analysis for both HIV prevalence and maternal mortality. Methodological caveats are noted under the Note section, addressing limitations. However, the Limitations label is not explicitly used, and some methodological caveats are embedded in the Note rather than a distinct Limitations section, preventing a perfect score.
- **Per-Turn Follow-up Suggestions**: 0.94 ✅
  - The response includes a 'Suggested follow-ups:' section with three clearly user-phrased questions, appropriately labeled and relevant to the data provided. The questions are phrased naturally from a user's perspective, fulfilling the rubric's highest criteria. However, minor improvements could be made to ensure all questions are explicitly phrased as direct user inquiries.
- **Per-Turn Latest Data Note**: 1.00 ✅
  - The response explicitly includes the latest available data years (2024 for HIV prevalence and 2023 for maternal mortality), fulfilling the rubric's highest standard. It also provides a clear note indicating the use of latest data and detailed year-by-year comparisons, directly addressing the user's request for the latest data and trend analysis over the past decade.
- **Per-Turn Source Citation**: 1.00 ✅
  - The response includes a clearly labeled 'Sources' section at the end, listing the World Bank World Development Indicators and specifying the indicators used with proper citation format. This meets the rubric criteria for a complete and correctly formatted sources section.
- **Per-Turn Data Formatting**: 1.00 ✅
  - The response includes units consistently for all values (e.g., % for HIV prevalence, per 100,000 live births for maternal mortality), presents data for three countries in well-structured markdown tables for the ten-year comparisons, and avoids any scientific notation. The formatting is clear, comprehensive, and aligns perfectly with the evaluation steps and rubric.
- **Per-Turn Inline Explanations**: 0.90 ✅
  - The response identifies key technical terms such as 'HIV prevalence,' 'maternal mortality ratio,' 'UNAIDS modeled estimates,' and 'MMEIG modeled estimates,' and provides clear, concise inline explanations on first use. Most terms are well contextualized, including acronyms like MMR and references to data sources. Minor room for improvement exists in explicitly defining some acronyms (e.g., ART) inline, but overall the explanations are thorough and integrated.
- **Per-Turn Progressive Disclosure**: 0.91 ✅
  - The response begins with a clear summary providing key insights on HIV prevalence and maternal mortality trends, fulfilling the first evaluation step. It presents structured data with progressive detail, including latest figures, ten-year comparisons, and intermediate points, avoiding excessive upfront data dumping. The inclusion of an analysis section synthesizes the data effectively. Additionally, the response offers multiple relevant follow-up questions for drill-down, meeting the third evaluation criterion. Minor markdown formatting and data density slightly reduce perfect flow, but overall it demonstrates strong structure and insight leadership.

</details>

<details>
<summary>🏷️ Claim IDs (86 tags)</summary>

- `3878cdc4` = 17.2 (new)
- `afe70664` = 15.7 (new)
- `e6455594` = 9.0 (new)
- `088c80ef` = 18.3 (new)
- `3878cdc4` = 17.2 (reused from Turn 1)
- `ded61aad` = 22.1 (new)
- `afe70664` = 15.7 (reused from Turn 1)
- `3dc2ac45` = 12.6 (new)
- `e6455594` = 9.0 (reused from Turn 1)
- `3bd56225` = 18.6 (new)
- `69a97918` = 18.6 (new)
- `4f47cc43` = 18.4 (new)
- `09b4cdd6` = 17.9 (new)
- `98d86436` = 17.6 (new)
- `ded61aad` = 22.1 (reused from Turn 1)
- `d89340fe` = 21.4 (new)
- `c99b16b6` = 20.3 (new)
- `624f618f` = 19.7 (new)
- `c986de9d` = 19.0 (new)
- `07d599a1` = 18.2 (new)
- `9a286d05` = 17.4 (new)
- `147d9d7a` = 16.6 (new)
- `afe70664` = 15.7 (reused from Turn 1)
- `3dc2ac45` = 12.6 (reused from Turn 1)
- `164c3672` = 12.4 (new)
- `c612e3c7` = 12.1 (new)
- `e0890327` = 11.8 (new)
- `eb101cb2` = 11.5 (new)
- `4275771c` = 11.1 (new)
- `0c611505` = 10.6 (new)
- `a5047eab` = 10.2 (new)
- `26482c53` = 9.8 (new)
- `1be9fe5f` = 9.4 (new)
- `e6455594` = 9.0 (reused from Turn 1)
- `b48a6b8f` = 118 (new)
- `513dd7a2` = 155 (new)
- `615382c8` = 139 (new)
- `35bfa15a` = 162 (new)
- `b48a6b8f` = 118 (reused from Turn 1)
- `74ff37f2` = 212 (new)
- `513dd7a2` = 155 (reused from Turn 1)
- `c166f92e` = 369 (new)
- `615382c8` = 139 (reused from Turn 1)
- `b8353256` = 150 (new)
- `57abc1d6` = 141 (new)
- `7851120f` = 134 (new)
- `8c3ba5b4` = 128 (new)
- `a8a15590` = 119 (new)
- `3d773beb` = 118 (new)
- `3a3134ac` = 191 (new)
- `82777120` = 129 (new)
- `b48a6b8f` = 118 (reused from Turn 1)
- `74ff37f2` = 212 (reused from Turn 1)
- `cb75c1b3` = 141 (new)
- `5aee03e6` = 72 (new)
- `5e3550fb` = 46 (new)
- `d73d660c` = 99 (new)
- `e3ada008` = 100 (new)
- `82b263ed` = 98 (new)
- `2d8554c5` = 165 (new)
- `6ca0eef0` = 120 (new)
- `513dd7a2` = 155 (reused from Turn 1)
- `c166f92e` = 369 (reused from Turn 1)
- `da1b25ea` = 307 (new)
- `3e88a750` = 250 (new)
- `ad3f0c01` = 213 (new)
- `036a441b` = 198 (new)
- `9f8bba70` = 175 (new)
- `67cf8fa4` = 143 (new)
- `d3255a18` = 254 (new)
- `a7abaffd` = 127 (new)
- `615382c8` = 139 (reused from Turn 1)
- `ded61aad` = 22.1 (reused from Turn 1)
- `afe70664` = 15.7 (reused from Turn 1)
- `3dc2ac45` = 12.6 (reused from Turn 1)
- `e6455594` = 9.0 (reused from Turn 1)
- `088c80ef` = 18.3 (reused from Turn 1)
- `3878cdc4` = 17.2 (reused from Turn 1)
- `35bfa15a` = 162 (reused from Turn 1)
- `b48a6b8f` = 118 (reused from Turn 1)
- `3a3134ac` = 191 (reused from Turn 1)
- `5aee03e6` = 72 (reused from Turn 1)
- `5e3550fb` = 46 (reused from Turn 1)
- `513dd7a2` = 155 (reused from Turn 1)
- `c166f92e` = 369 (reused from Turn 1)
- `615382c8` = 139 (reused from Turn 1)

</details>


### User (Turn 2)

Please provide comparative line charts for HIV prevalence and maternal mortality trends in South Africa, Botswana, and Namibia over the past 20 years, including clear labels and data source notes.

### Assistant

<details>
<summary>🔍 Agent Actions (6 events, 2 tool calls)</summary>

**🧭 Routing**

Understanding your question…User requests comparative line charts of HIV prevalence and maternal mortality over 20 years for specific countries, which requires pulling World Bank/UNAIDS/MMEIG time-series data and presenting it visually with proper metadata and source notes.

<hr>

**🔧 Tool Call #1: `data360_get_viz_spec`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_DYN_AIDS_ZS
  country_code: ZAF,BWA,NAM
  start_year: 2004
  end_year: 2024
  chart_type: line chart
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "url": "http://localhost:8000/static/viz_specs/8efe42f7-57dd-4422-997e-ef07fca8a815_vega.json",
  "error": null
}
```

</details>

<hr>

**🔧 Tool Call #2: `data360_get_viz_spec`**
```
  database_id: WB_WDI
  indicator_id: WB_WDI_SH_STA_MMRT
  country_code: ZAF,BWA,NAM
  start_year: 2004
  end_year: 2023
  chart_type: line chart
```

<hr>

<details>
<summary>Tool Output</summary>

```json
{
  "url": "http://localhost:8000/static/viz_specs/c148a002-8f13-426d-b0e2-f543992c48a9_vega.json",
  "error": null
}
```

</details>

<hr>

**🧠 Thinking** (stage: interpreting)

**Summary:** Here are two comparative line charts for South Africa, Botswana, and Namibia over the last 20 years—one for HIV prevalence (ages 15–49) and one for maternal mortality. Each uses harmonized World Bank/UN indicators.

<hr>

## Data

### 1. HIV prevalence, adults 15–49 (%), 2004–2024  

**Chart:**  
[Comparative HIV prevalence, ages 15–49, South Africa vs Botswana vs Namibia (2004–2024)](http://localhost:8000/static/viz_specs/8efe42f7-57dd-4422-997e-ef07fca8a815_vega.json)

- Indicator: **Prevalence of HIV, total (% of population ages 15–49)**  
- Indicator ID: `WB_WDI_SH_DYN_AIDS_ZS`  
- Countries: South Africa (ZAF), Botswana (BWA), Namibia (NAM)  
- Period: 2004–2024 (annual)  

**How to read the chart (structure):**

- X‑axis: Year (2004–2024)  
- Y‑axis: HIV prevalence (%) among adults 15–49  
- Lines: One line per country (South Africa, Botswana, Namibia), clearly labeled or color‑coded in the legend.  

**Data source note (for your figure caption):**  
“Source: World Bank, World Development Indicators (WDI), indicator SH.DYN.AIDS.ZS (UNAIDS modeled estimates).”

<hr>

### 2. Maternal mortality ratio (per 100,000 live births), 2004–2023  

**Chart:**  
[Comparative maternal mortality ratio, South Africa vs Botswana vs Namibia (2004–2023)](http://localhost:8000/static/viz_specs/c148a002-8f13-426d-b0e2-f543992c48a9_vega.json)

- Indicator: **Maternal mortality ratio (modeled estimate, per 100,000 live births)**  
- Indicator ID: `WB_WDI_SH_STA_MMRT`  
- Countries: South Africa (ZAF), Botswana (BWA), Namibia (NAM)  
- Period: 2004–2023 (annual)  

**How to read the chart (structure):**

- X‑axis: Year (2004–2023)  
- Y‑axis: Maternal deaths per 100,000 live births  
- Lines: One line per country, clearly labeled or color‑coded in the legend.  

**Data source note (for your figure caption):**  
“Source: World Bank, World Development Indicators (WDI), indicator SH.STA.MMRT — WHO/UNICEF/UNFPA/World Bank/UN DESA Maternal Mortality Estimation Inter‑Agency Group (MMEIG) modeled estimates.”

<hr>

## Analysis (very brief)

- The **HIV prevalence chart** will show persistently high levels in all three countries, with a noticeable decline in Botswana and Namibia, and a more modest decline in South Africa.  
- The **maternal mortality chart** will show overall declines over 20 years, with some volatility and visible spikes around the COVID‑19 period (especially 2020–2021).

<hr>

## Suggested follow-ups

1. Could you provide downloadable CSV links or an API example for these exact country–indicator combinations so I can pull the data into my own analysis?  
2. Can you add regional comparison lines (e.g., Sub‑Saharan Africa average) to these charts?  
3. Can you help quantify the percentage change in HIV prevalence and maternal mortality over the last 20 years for each country?

</details>

<details open>
<summary>✍️ Writer</summary>

**Summary:** Here are two comparative line charts for South Africa, Botswana, and Namibia over the last 20 years—one for HIV prevalence (ages 15–49) and one for maternal mortality. Each uses harmonized World Bank/UN indicators.

---

## Data

### 1. HIV prevalence, adults 15–49 (%), 2004–2024  

**Chart:**  
[Comparative HIV prevalence, ages 15–49, South Africa vs Botswana vs Namibia (2004–2024)](http://localhost:8000/static/viz_specs/8efe42f7-57dd-4422-997e-ef07fca8a815_vega.json)

- Indicator: **Prevalence of HIV, total (% of population ages 15–49)**  
- Indicator ID: `WB_WDI_SH_DYN_AIDS_ZS`  
- Countries: South Africa (ZAF), Botswana (BWA), Namibia (NAM)  
- Period: 2004–2024 (annual)  

**How to read the chart (structure):**

- X‑axis: Year (2004–2024)  
- Y‑axis: HIV prevalence (%) among adults 15–49  
- Lines: One line per country (South Africa, Botswana, Namibia), clearly labeled or color‑coded in the legend.  

**Data source note (for your figure caption):**  
“Source: World Bank, World Development Indicators (WDI), indicator SH.DYN.AIDS.ZS (UNAIDS modeled estimates).”

---

### 2. Maternal mortality ratio (per 100,000 live births), 2004–2023  

**Chart:**  
[Comparative maternal mortality ratio, South Africa vs Botswana vs Namibia (2004–2023)](http://localhost:8000/static/viz_specs/c148a002-8f13-426d-b0e2-f543992c48a9_vega.json)

- Indicator: **Maternal mortality ratio (modeled estimate, per 100,000 live births)**  
- Indicator ID: `WB_WDI_SH_STA_MMRT`  
- Countries: South Africa (ZAF), Botswana (BWA), Namibia (NAM)  
- Period: 2004–2023 (annual)  

**How to read the chart (structure):**

- X‑axis: Year (2004–2023)  
- Y‑axis: Maternal deaths per 100,000 live births  
- Lines: One line per country, clearly labeled or color‑coded in the legend.  

**Data source note (for your figure caption):**  
“Source: World Bank, World Development Indicators (WDI), indicator SH.STA.MMRT — WHO/UNICEF/UNFPA/World Bank/UN DESA Maternal Mortality Estimation Inter‑Agency Group (MMEIG) modeled estimates.”

---

## Analysis (very brief)

- The **HIV prevalence chart** will show persistently high levels in all three countries, with a noticeable decline in Botswana and Namibia, and a more modest decline in South Africa.  
- The **maternal mortality chart** will show overall declines over 20 years, with some volatility and visible spikes around the COVID‑19 period (especially 2020–2021).

---

## Suggested follow-ups

1. Could you provide downloadable CSV links or an API example for these exact country–indicator combinations so I can pull the data into my own analysis?  
2. Can you add regional comparison lines (e.g., Sub‑Saharan Africa average) to these charts?  
3. Can you help quantify the percentage change in HIV prevalence and maternal mortality over the last 20 years for each country?

</details>

<details>
<summary>📝 Per-Turn Scores</summary>

- **Per-Turn Claim Consistency**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Latest Data Note**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Formatting**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Accuracy**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Content Structure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Comparability Warnings**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Progressive Disclosure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Follow-up Suggestions**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Source Citation**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Gap Handling**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Context Retention**: 0.90 ✅
  - The response correctly retains context by using the same indicator IDs (WB_WDI_SH_DYN_AIDS_ZS and WB_WDI_SH_STA_MMRT) and country codes as in prior turns, maintaining data provenance. It does not re-search resolved indicators and maintains consistency with prior data availability, providing clear labels and data source notes. Minor deduction is due to the brief analysis rather than deeper integration of prior numeric claims.
- **Per-Turn Inline Explanations**: 0.90 ✅
  - The response identifies key technical terms such as 'HIV prevalence,' 'maternal mortality ratio,' and indicator codes (e.g., WB_WDI_SH_DYN_AIDS_ZS) and provides clear, concise inline explanations on first use, including age ranges and units. Data source notes are included for transparency. The explanations are well integrated and mostly comprehensive, though a minor improvement could be made by explicitly defining acronyms like ART or UNAIDS within the text. Overall, the response meets the rubric criteria for explaining most terms inline.

</details>


### User (Turn 3)

Could you please explain the data collection methods and modeling approaches used for these HIV prevalence and maternal mortality estimates, including any known limitations or uncertainties?

### Assistant

<details>
<summary>🔍 Agent Actions (1 events, 0 tool calls)</summary>

**🧭 Routing**

Understanding your question…The user is asking specifically about the data collection methods, modeling approaches, and limitations for two WDI indicators (HIV prevalence SH.DYN.AIDS.ZS and maternal mortality SH.STA.MMRT). This is exactly the kind of metadata/explanatory information that comes from Data360/World Bank tools, so it should be answered via RESEARCH.

</details>

<details open>
<summary>✍️ Writer</summary>



**Summary:** Both indicators you’re using are *modeled estimates*, not raw counts. HIV prevalence comes from UNAIDS’ Spectrum modeling framework; maternal mortality comes from the Maternal Mortality Estimation Inter‑Agency Group (MMEIG). In both cases, the models combine incomplete country data with demographic and health covariates, and the official metadata stresses substantial uncertainty and limited comparability for fine‑grained or short‑term analysis.

---

## Data

You’re using:

- **HIV prevalence** — *Prevalence of HIV, total (% of population ages 15–49)*  
  - Indicator ID: `WB_WDI_SH_DYN_AIDS_ZS`  
  - Source: UNAIDS estimates (via World Bank WDI)

- **Maternal mortality** — *Maternal mortality ratio (modeled estimate, per 100,000 live births)*  
  - Indicator ID: `WB_WDI_SH_STA_MMRT`  
  - Source: WHO/UNICEF/UNFPA/World Bank/UN DESA MMEIG (via World Bank WDI)

---

## Analysis

### 1. HIV prevalence (UNAIDS / Spectrum model)

**What data go into the model?**

According to the indicator metadata for `WB_WDI_SH_DYN_AIDS_ZS`, UNAIDS uses a common modeling framework (Spectrum) that integrates:

- **HIV surveillance data**, such as:
  - Sentinel surveillance among pregnant women attending antenatal clinics (ANC)  
  - Population‑based HIV seroprevalence surveys (e.g., DHS, PHIA, national HIV surveys)  
  - Key population surveys where available
- **Program data**, including:
  - Numbers on antiretroviral therapy (ART)  
  - Prevention of mother‑to‑child transmission (PMTCT) coverage  
  - HIV testing volumes and positivity
- **Demographic data**:
  - Population by age and sex (UN population estimates)  
  - Fertility patterns, mortality patterns
- **Assumptions from epidemiological research**:
  - Patterns of HIV transmission  
  - Disease progression and survival with and without treatment

The metadata notes that UNAIDS “produces annual HIV/AIDS-related indicators using a common modelling framework (Spectrum). The model integrates country-reported data on HIV surveillance, antiretroviral therapy (ART) coverage, demographic information, and established patterns of HIV transmission, disease progression, and survival.”

**How does the modeling work (conceptually)?**

- **Step 1: Fit epidemic curves**  
  - For each country, UNAIDS fits an epidemic curve to surveillance and survey data, estimating the annual number of new infections (incidence) over time.
- **Step 2: Simulate disease progression**  
  - Using assumptions about time from infection to AIDS and death, and the effect of ART on survival, the model “ages” each infection cohort forward in time.
- **Step 3: Combine with population data**  
  - The model overlays these infection and survival trajectories on demographic projections (population by age/sex) to estimate:
    - Number of people living with HIV by age/sex/year  
    - Prevalence = (people living with HIV) / (population) in the 15–49 age group.
- **Step 4: Calibration and uncertainty**  
  - The model is calibrated against observed survey prevalence and program data.  
  - UNAIDS generates **uncertainty ranges** around the estimates (not shown in the WDI series, but present in UNAIDS reports).

**Known limitations and uncertainties (from metadata and practice):**

- **Modeled, not measured:**  
  - These are not direct counts of HIV‑positive individuals; they are model outputs integrating multiple imperfect data sources.
- **Data gaps and quality:**
  - Many countries lack complete or frequent HIV prevalence surveys; surveillance systems may be biased (e.g., ANC data may not represent all women, let alone men or key populations).  
  - The metadata explicitly notes: “The limited availability of data on health status is a major constraint… Estimates of prevalence and incidence are often unreliable and incomplete.”
- **Changes in methods over time:**
  - UNAIDS periodically updates methods, assumptions, and input data. Historical estimates can be revised, so time series can change between releases.
- **Hidden epidemics:**
  - The statistical concept note warns that **low national prevalence can hide concentrated epidemics** in specific groups or regions. The reverse is also true: national averages can obscure local improvements or deteriorations.
- **Uncertainty not visible in WDI:**
  - WDI publishes point estimates only; the uncertainty intervals (which can be wide, especially for smaller countries) are not visible, so the apparent precision is misleading.

**Implications for your analysis:**

- Use HIV prevalence series to describe **broad trends and relative levels**, not to interpret small year‑to‑year fluctuations as real changes.  
- Be explicit that these are **UNAIDS modeled estimates** and that uncertainty bands are not shown in the WDI series you’re using.

---

### 2. Maternal mortality ratio (MMEIG modeled estimates)

**What data go into the model?**

The metadata for `WB_WDI_SH_STA_MMRT` explains that the Maternal Mortality Estimation Inter‑Agency Group (MMEIG — WHO, UNICEF, UNFPA, World Bank, UN DESA) uses:

- **Vital registration data** (where available):
  - Civil registration and vital statistics (CRVS) with cause‑of‑death information, classified by ICD codes.
- **Household survey data**:
  - Demographic and Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS), and other national surveys that measure maternal mortality via “sisterhood” methods (asking about survival of sisters).
- **Special studies and confidential enquiries**:
  - Facility‑based studies, confidential enquiries into maternal deaths, and other country reports.
- **Covariates and contextual data**:
  - GDP per capita (PPP)  
  - General fertility rate  
  - Skilled birth attendance and other health‑service indicators  
  - Sometimes HIV prevalence and other health system factors

The metadata states: “For countries without complete registration data but with other types of data and for countries with no data, maternal mortality is estimated with a regression model using available national maternal mortality data and socioeconomic information.”

**How does the modeling work (conceptually)?**

- **Step 1: Assess data quality by country**
  - Countries are classified by the availability and quality of CRVS and other data.  
  - Where CRVS is strong, models adjust observed maternal deaths for known under‑reporting or misclassification.
- **Step 2: Statistical regression model**
  - For countries with limited or no reliable data, MMEIG uses a **regression model** that links maternal mortality to covariates (e.g., GDP per capita, fertility, health service coverage, HIV context).
- **Step 3: Time series smoothing and consistency**
  - The model generates a **time series** from 1985 onward, smoothing noisy or sparse data and ensuring internal consistency across years and countries.
- **Step 4: Uncertainty estimation**
  - MMEIG computes **uncertainty intervals** around each estimate, reflecting data quality and model uncertainty (again, not visible in the WDI point series).

**Known limitations and uncertainties (as highlighted in the metadata):**

- **Historical comparability is limited:**  
  - The metadata explicitly warns: “The methodology differs from that used for previous estimates, so data should not be compared historically.”  
  - This means that long time‑series comparisons across methodological revisions (e.g., pre‑ and post‑2015) must be interpreted cautiously.
- **Unknown reliability of cause‑specific mortality:**
  - Even in high‑income countries with good vital registration, **misclassification of maternal deaths is common** and can seriously underestimate true maternal mortality.  
  - In low‑ and middle‑income settings, CRVS is often incomplete or absent, so reliance on surveys and models is high.
- **Survey methods have structural limitations:**
  - Sisterhood methods (asking about sisters’ deaths) produce estimates that refer to a period **several years before the survey**, not the current year.  
  - This makes them unsuitable for monitoring very recent changes or short‑term impacts of interventions.
- **Model dependence:**
  - For many countries, especially where data are weak, the estimates are heavily driven by the **regression model structure and covariates**, not direct observation.  
  - As the metadata notes, “Maternal mortality ratios are generally of unknown reliability… The ratios cannot be assumed to provide an exact estimate of maternal mortality.”
- **Apparent year‑to‑year changes may be artifacts:**
  - Because the model smooths and fits across all years, small year‑to‑year changes (or even some spikes/drops) can reflect model behavior or data revisions rather than true underlying changes.

**Implications for your analysis:**

- Use MMR series to describe **long‑term direction and approximate magnitude**, not precise year‑to‑year movements.  
- Be especially cautious about:
  - Comparing pre‑ and post‑methodology‑revision periods as if they were on exactly the same scale.  
  - Interpreting single‑year anomalies (e.g., spikes around COVID‑19) without triangulating with country reports or other data.
- In your write‑up, it’s good practice to include language such as:
  - “Maternal mortality ratios are modeled estimates produced by the MMEIG; true values may differ, and uncertainty intervals are not shown here.”

---

## Limitations (cross‑cutting)

Across both indicators:

- **Not directly observed counts:** Both HIV prevalence and MMR are **statistical models** combining multiple imperfect data sources.
- **Uncertainty not visible in WDI:** The underlying agencies publish uncertainty ranges; WDI typically presents only point estimates, which can appear more precise than they really are.
- **Methodological updates:** Changes in model structure, input data, and assumptions can lead to **revisions of past years**, complicating strict historical comparisons.
- **National averages only:** Both indicators are **national aggregates**; they can hide large sub‑national or subgroup disparities (e.g., by province, wealth quintile, or ethnicity).

---

## Sources

- **World Bank — World Development Indicators (WDI)**  
  - *Prevalence of HIV, total (% of population ages 15–49)* — WB_WDI_SH_DYN_AIDS_ZS  
    - Methodology summary: UNAIDS Spectrum modeling framework; integrates surveillance, ART coverage, demographic data, and patterns of transmission and survival.  
  - *Maternal mortality ratio (modeled estimate, per 100,000 live births)* — WB_WDI_SH_STA_MMRT  
    - Methodology summary: MMEIG regression model using maternal mortality data (where available) plus socioeconomic and health covariates.

- **Primary technical references (from metadata):**  
  - UNAIDS Spectrum methods (Annex 1 of the Global AIDS Update).  
  - WHO/UNICEF/UNFPA/World Bank/UN DESA “Trends in Maternal Mortality” methodological documentation.

---

**Suggested follow-ups:**

1. Could you help me draft a short “methods and limitations” section for a paper that uses these indicators for South Africa, Botswana, and Namibia?  
2. Can you suggest complementary indicators (e.g., skilled birth attendance, ART coverage, ANC coverage) to triangulate these modeled estimates?  
3. Can you show how to pull the underlying series (with codes) via API so I can re‑create the trends in R or Python with appropriate caveats?

</details>

<details>
<summary>📝 Per-Turn Scores</summary>

- **Per-Turn Claim Consistency**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Latest Data Note**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Formatting**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Accuracy**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Content Structure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Comparability Warnings**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Progressive Disclosure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Follow-up Suggestions**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Source Citation**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Gap Handling**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Context Retention**: 0.94 ✅
  - The response correctly retains context by referencing the same indicator IDs (WB_WDI_SH_DYN_AIDS_ZS and WB_WDI_SH_STA_MMRT) used in prior turns, maintaining data provenance. It does not re-search resolved indicators and consistently presents the modeled nature and uncertainties of the HIV prevalence and maternal mortality estimates, aligning with prior assertions about data limitations. Minor deduction is due to the lack of explicit mention of claim_ids in numeric references, but overall consistency and context retention are strong.
- **Per-Turn Inline Explanations**: 0.96 ✅
  - The response identifies all key technical terms and acronyms such as HIV prevalence, UNAIDS Spectrum model, MMEIG, ART, PMTCT, CRVS, and sisterhood methods, providing clear, concise, and inline plain-language explanations on first use. It thoroughly explains data sources, modeling steps, and known limitations for both HIV prevalence and maternal mortality estimates, meeting the highest rubric standard.

</details>


### User (Turn 4)

Could you help me draft a concise methods and limitations section for my paper using these HIV prevalence and maternal mortality indicators for South Africa, Botswana, and Namibia?

### Assistant

<details>
<summary>🔍 Agent Actions (2 events, 0 tool calls)</summary>

**🧭 Routing**

Understanding your question…User is writing a paper based on specific WDI indicators (HIV prevalence and maternal mortality) and needs a methods & limitations section; this relies on indicator metadata and methodological notes from the data providers.

<hr>

**🧠 Thinking** (stage: interpreting)

**Methods**

This analysis uses nationally aggregated annual estimates from the World Bank’s World Development Indicators (WDI) for South Africa, Botswana, and Namibia over the most recent available two decades. HIV burden is measured using **Prevalence of HIV, total (% of population ages 15–49)** (indicator code SH.DYN.AIDS.ZS), and maternal health outcomes are measured using **Maternal mortality ratio (modeled estimate, per 100,000 live births)** (indicator code SH.STA.MMRT).

HIV prevalence estimates are produced by the Joint United Nations Programme on HIV/AIDS (UNAIDS) using the **Spectrum** modeling framework. Spectrum integrates country‑reported HIV surveillance data (e.g., antenatal clinic sentinel surveillance, population‑based HIV serosurveys), program data (e.g., antiretroviral therapy and PMTCT coverage), demographic projections, and established assumptions on HIV transmission, disease progression, and survival. For each country, the model fits epidemic curves and simulates the number of people living with HIV by age and sex; prevalence among adults 15–49 is calculated as the ratio of modeled HIV‑positive adults to the corresponding population.

Maternal mortality ratios are estimated by the **Maternal Mortality Estimation Inter‑Agency Group (MMEIG)**, comprising WHO, UNICEF, UNFPA, the World Bank, and UN DESA. Depending on data availability and quality, the MMEIG approach combines civil registration and vital statistics with cause‑of‑death information, specialized studies, and household surveys (e.g., DHS, MICS) with “sisterhood” modules. For countries with incomplete or no reliable data, a regression model relates maternal mortality to socioeconomic and health‑system covariates (e.g., GDP per capita, fertility, and service coverage indicators), and produces a smoothed time series of maternal mortality ratios per 100,000 live births. The World Bank disseminates these UNAIDS and MMEIG estimates as harmonized WDI series, which are used here without further adjustment.

**Limitations**

Both indicators are **modeled estimates rather than direct counts**, and should be interpreted accordingly. For HIV prevalence, the Spectrum model is sensitive to the availability and quality of surveillance and survey data; in settings with sparse or biased data (e.g., limited population‑based surveys, non‑representative ANC surveillance), model outputs may carry substantial uncertainty. National prevalence averages may also mask concentrated epidemics in specific subpopulations or regions, limiting the ability to draw conclusions about intra‑country inequities.

For maternal mortality, the MMEIG explicitly notes that maternal mortality ratios are of **unknown reliability in many settings**, given pervasive under‑reporting and misclassification of maternal deaths, even where civil registration systems exist. In countries lacking robust vital registration, estimates are heavily driven by the regression model and covariates rather than observed maternal deaths. Moreover, the MMEIG methodology has been revised over time; as a result, historical estimates are not strictly comparable across major methodological updates, and long‑term trends should be interpreted as indicative rather than precise. Household survey‑based measures (e.g., sisterhood methods) typically refer to periods several years prior to the survey, further complicating the interpretation of recent year‑to‑year changes.

A further limitation is that the WDI series used in this analysis provide **point estimates only**, while the underlying agencies publish uncertainty intervals that can be wide, particularly for smaller countries or earlier years. Because uncertainty bounds are not incorporated here, the apparent precision of annual values is overstated, and small inter‑annual differences should not be over‑interpreted as real changes. Finally, all indicators are **national aggregates** and do not capture sub‑national, socioeconomic, or other within‑country disparities in HIV burden or maternal mortality risk.

<hr>

If you’d like, I can help tailor this section to a specific journal style (e.g., adding in‑text citations or shortening to a strict word limit).

</details>

<details open>
<summary>✍️ Writer</summary>

**Methods**

This analysis uses nationally aggregated annual estimates from the World Bank’s World Development Indicators (WDI) for South Africa, Botswana, and Namibia over the most recent available two decades. HIV burden is measured using **Prevalence of HIV, total (% of population ages 15–49)** (indicator code SH.DYN.AIDS.ZS), and maternal health outcomes are measured using **Maternal mortality ratio (modeled estimate, per 100,000 live births)** (indicator code SH.STA.MMRT).

HIV prevalence estimates are produced by the Joint United Nations Programme on HIV/AIDS (UNAIDS) using the **Spectrum** modeling framework. Spectrum integrates country‑reported HIV surveillance data (e.g., antenatal clinic sentinel surveillance, population‑based HIV serosurveys), program data (e.g., antiretroviral therapy and PMTCT coverage), demographic projections, and established assumptions on HIV transmission, disease progression, and survival. For each country, the model fits epidemic curves and simulates the number of people living with HIV by age and sex; prevalence among adults 15–49 is calculated as the ratio of modeled HIV‑positive adults to the corresponding population.

Maternal mortality ratios are estimated by the **Maternal Mortality Estimation Inter‑Agency Group (MMEIG)**, comprising WHO, UNICEF, UNFPA, the World Bank, and UN DESA. Depending on data availability and quality, the MMEIG approach combines civil registration and vital statistics with cause‑of‑death information, specialized studies, and household surveys (e.g., DHS, MICS) with “sisterhood” modules. For countries with incomplete or no reliable data, a regression model relates maternal mortality to socioeconomic and health‑system covariates (e.g., GDP per capita, fertility, and service coverage indicators), and produces a smoothed time series of maternal mortality ratios per 100,000 live births. The World Bank disseminates these UNAIDS and MMEIG estimates as harmonized WDI series, which are used here without further adjustment.

**Limitations**

Both indicators are **modeled estimates rather than direct counts**, and should be interpreted accordingly. For HIV prevalence, the Spectrum model is sensitive to the availability and quality of surveillance and survey data; in settings with sparse or biased data (e.g., limited population‑based surveys, non‑representative ANC surveillance), model outputs may carry substantial uncertainty. National prevalence averages may also mask concentrated epidemics in specific subpopulations or regions, limiting the ability to draw conclusions about intra‑country inequities.

For maternal mortality, the MMEIG explicitly notes that maternal mortality ratios are of **unknown reliability in many settings**, given pervasive under‑reporting and misclassification of maternal deaths, even where civil registration systems exist. In countries lacking robust vital registration, estimates are heavily driven by the regression model and covariates rather than observed maternal deaths. Moreover, the MMEIG methodology has been revised over time; as a result, historical estimates are not strictly comparable across major methodological updates, and long‑term trends should be interpreted as indicative rather than precise. Household survey‑based measures (e.g., sisterhood methods) typically refer to periods several years prior to the survey, further complicating the interpretation of recent year‑to‑year changes.

A further limitation is that the WDI series used in this analysis provide **point estimates only**, while the underlying agencies publish uncertainty intervals that can be wide, particularly for smaller countries or earlier years. Because uncertainty bounds are not incorporated here, the apparent precision of annual values is overstated, and small inter‑annual differences should not be over‑interpreted as real changes. Finally, all indicators are **national aggregates** and do not capture sub‑national, socioeconomic, or other within‑country disparities in HIV burden or maternal mortality risk.

---

If you’d like, I can help tailor this section to a specific journal style (e.g., adding in‑text citations or shortening to a strict word limit).

</details>

<details>
<summary>📝 Per-Turn Scores</summary>

- **Per-Turn Claim Consistency**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Latest Data Note**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Formatting**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Accuracy**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Content Structure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Comparability Warnings**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Progressive Disclosure**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Follow-up Suggestions**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Source Citation**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Data Gap Handling**: 1.00 ✅
  - N/A — pre-filtered (metric not applicable to this turn).
- **Per-Turn Context Retention**: 0.95 ✅
  - The response correctly retains context by providing detailed methods and limitations consistent with prior turns, referencing the same indicators without inventing new claim_ids or contradicting earlier data availability assertions. It avoids re-searching resolved indicators and maintains consistency about modeled estimates and their uncertainties, though it does not explicitly cite claim_ids, which slightly limits perfect provenance tracking.
- **Per-Turn Inline Explanations**: 0.99 ✅
  - The response identifies all key technical terms and acronyms such as HIV prevalence, maternal mortality ratio, UNAIDS, Spectrum model, and MMEIG, providing clear, concise, and inline explanations on first use. The methods and limitations sections thoroughly explain the data sources, modeling approaches, and known uncertainties, adhering closely to the evaluation steps and rubric by ensuring all terms are well-defined and contextualized.

</details>
